Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Sheng Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4153-3546; OpenAlex author ID A5025565899. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 5

  1. IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion. Last author DOI 10.1038/s41419-025-08155-1↗
  2. Development and Validation of a Nomogram for Preoperative Prediction of Early Recurrence after Upfront Surgery in Pancreatic Ductal Adenocarcinoma by Integrati… Last author DOI 10.3390/cancers15143543↗
  3. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer. Last author DOI 10.3892/or.2023.8585↗
  4. A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospective study. Last author DOI 10.7150/jca.61101↗
  5. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Co-author DOI 10.1016/s1499-3872(15)60400-3↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingyu Liu · 2 shared papers, 2021–2025 · strength 0.38
  2. Hengqing Zhu · 1 shared paper, 2025 · strength 0.22
  3. Long Liu · 1 shared paper, 2025 · strength 0.22
  4. Sinan Lu · 1 shared paper, 2023 · strength 0.22
  5. Yingfang Fan · 1 shared paper, 2023 · strength 0.20
  6. Fei Xiang · 1 shared paper, 2023 · strength 0.20
  7. Xiaoyuan Liang · 1 shared paper, 2021 · strength 0.16
  8. Shusen Zheng · 1 shared paper, 2015 · strength 0.06
  9. Min Zhang · 1 shared paper, 2015 · strength 0.06
  10. Weilin Wang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.